Summit Therapeutics (SMMT) on Sunday said its experimental cancer drug ivonescimab helped patients with advanced biliary ...
Daily Mail on MSN
Michelle thought she had a stomach bug. Her diagnosis exposes Australia's growing cancer crisis
When Sydney makeup artist Michelle Dubé felt mildly nauseous, she assumed she'd eaten something bad. Just one week later, ...
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard ...
If you’re looking into HRT options and interested in trying a topical HRT cream, here’s a look at how it compares to other ...
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announced today that it will open a randomized, registration-enabling phase 2/3 clinical trial to evaluate ivonescimab combined with chemotherapy as ...
Can I be prescribed it too?This is a question I frequently receive on our official LINE account. I am Dr. Nakayama, and I ...
As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...
Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Researc ...
As a screening test from Grail moves closer to Food and Drug Administration approval, cancer experts share what encourages ...
Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that its partner Akeso Inc. announced positive results from the Phase III ...
Still, when it comes to GLP-1 injectables and pills, not all is as it seems. Hundreds of women responded to a Reddit inquiry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results